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Background. Tuberculosis (TB) is diﬃcult to diagnose in children due to lack of a gold standard, especially in resource-limited
settings. Scoring systems and diagnostic criteria are often used to assist in diagnosis; however their validity, especially in areas
with high HIV prevalence, remains unclear. Methods. We searched online bibliographic databases, including MEDLINE and
EMBASE. We selected all studies involving scoring systems or diagnostic criteria used to aid in the diagnosis of tuberculosis in
children and extracted data from these studies. Results. The search yielded 2261 titles, of which 40 met selection criteria. Eighteen
studies used point-based scoring systems. Eighteen studies used diagnostic criteria. Validation of these scoring systems yielded
varying sensitivities as gold standards used ranged widely. Four studies evaluated and compared multiple scoring criteria. Ten
studies selected for pulmonary tuberculosis. Five studies specifically evaluated the use of scoring systems in HIV-positive children,
generally finding the specificity to be lower. Conclusions. Though scoring systems and diagnostic criteria remain widely used in
the diagnosis of tuberculosis in children, validation has been diﬃcult due to lack of an established and accessible gold standard.
Estimates of sensitivity and specificity vary widely, especially in populations with high HIV co-infection.
1. Background
Tuberculosis (TB) remains one of the most important causes
of pediatric mortality worldwide, especially in areas with
high HIV prevalence. There are approximately nine million
new TB cases each year, with ten percent of those occurring
in children, equaling almost one million new pediatric cases
each year. Seventy-five percent of those are in twenty-
two high-burden countries, which also tend to have fewer
resources for diagnosis. Accurate and timely diagnosis of
pediatric TB remains crucial because children are more likely
than adults to progress from latent infection to active TB
disease [1].
One of the largest challenges in preventingmorbidity and
mortality from TB among the pediatric population is the dif-
ficulty in making a timely diagnosis. Diagnostic approaches
relying on symptoms, chest radiographs, tuberculin skin
tests, or cultures all have particular challenges within the
pediatric population. TB symptoms vary and overlap with
other common pediatric diseases, especially in children who
are coinfected with TB andHIV. Cough, anorexia, andweight
loss are common in TB but nonspecific and might lead to
overdiagnosis if used alone [2].
Chest radiography also is diﬃcult to interpret in pediatric
patients, who are less likely to have cavitations or clear
radiological signs of TB. Mediastinal lymphadenopathy is
often regarded as a radiologic hallmark of primary TB;
however, this is diﬃcult to diagnose on a plain chest X-
ray (CXR), which may be of variable quality, particularly
in some resource-limited settings. Also, significant interob-
server variation exists when interpreting pediatric CXR for
TB diagnosis [3].
Previous studies have shown various utility in using
the tuberculin skin test (TST) in a highly BCG vaccinated
population due to a concern for a high rate of false positives
[4]. Though some evidence has shown that BCG-vaccinated
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children with known exposure to TB have a higher rate of
positive tests than community controls [5], this study did
not address the utility in other populations where TST may
not be as sensitive, such as HIV-infected or malnourished
children.
Pediatric TB tends to be pauci-bacillary and thus it is
also more diﬃcult to diagnose using cultures, especially in
children who are too young to provide sputum [1]. Attempts
have been made to improve the utility of culture-proven
diagnosis by using induced sputum samples or gastric aspi-
rates. These samples can still be diﬃcult to obtain in children.
Moreover, conducting these procedures in resource-limited
settings can be diﬃcult [6]. Because of the challenges in
diagnosing pediatric TB through individual clinical signs and
symptoms, radiological studies, or laboratory examinations,
point-based scoring systems or diagnostic criteria are often
used to assist in the diagnosis of TB in children.
The first major point-based scoring system was intro-
duced by Stegen et al. in Chile in 1969 [7] and has continued
to be modified and used around the world through the
present [8–14]. The Keith Edwards criteria were originally
published in 1987 [15] and also have been widely used [16–
19] outside the original location of Papua New Guinea. Of
the many diagnostic systems developed, the World Health
Organization (WHO) criteria, originally published in 1983,
are the most widely used [20]. The major objective of all of
the diagnostic systems is to provide a consistent and accurate
way to diagnose pediatric TB, especially in resource-limited
settings.
Although these scoring systems and diagnostic criteria
are commonly used [21], their reliability and validity remain
unclear. Diﬀerent diagnostic criteria are used in diﬀerent
settings, and they may or may not have been validated
for those locations. Moreover, the challenges of using these
criteria in settings where many of the children are malnour-
ished or coinfected with HIV have not been fully examined.
Many of the diagnostic systems were developed prior to the
onset of the HIV epidemic and may not perform adequately
in children with coinfection. Since TB is a leading cause
of mortality among the world’s 2.3 million HIV-infected
children, diagnosing TB among coinfected children is a
particularly important challenge and may require significant
adaptations of current diagnostic systems [22].
Prevention of childhood morbidity and mortality due
to TB requires accurate and timely diagnosis. A previous
systematic review of pediatric TB diagnostic strategies, pub-
lished in 2002, recommended standardization of definitions
and characteristics, pointing out the need for new diagnostic
approaches [21]. Since that review, at least twenty-one new
papers on pediatric TB diagnosis have been published,
including several highlighting new strategies such as the
Brazil Ministry of Health system [23–25] and the Marais
criteria [26]. In addition, the population of children living
with HIV infection has reached 2.3 million, simultaneously
expanding the numbers of children vulnerable to TB disease
[22]. This systematic review seeks to systematically identify,
review, and compare various methods of diagnosis of TB
in children in order to inform clinical practice and future
research in this area. It aims to organize the scoring systems
and diagnostic criteria based on their common components,
critically analyze the extent to which the criteria are vali-
dated, and highlight those that have focused specifically on
children that are coinfected with HIV and TB.
2. Methods
We searched several bibliographic databases, including
MEDLINE (through October 19, 2009), EMBASE, and
relevant websites such as those for the World Health
Organization. We used the following strategy: (tuberculo-
sis/diagnosis) [MeSH heading] AND (criteria∗ OR screen∗
OR guideline∗ OR scor∗). Three authors (S. O. Ayaya, J.
F. Woodward, and E. C. Pearce) reviewed all returned titles
and excluded articles that obviously did not involve children
or tuberculosis. These authors then reviewed abstracts of
remaining articles to determine which studies examined
scoring systems or diagnostic criteria used in the diagnosis
of pediatric tuberculosis. The bibliographies of all relevant
articles were also reviewed for potential articles.
Two investigators (J. F.Woodward and E. C. Pearce) inde-
pendently reviewed the remaining articles, independently
deciding on inclusion in the review using a standard form
with predetermined eligibility criteria. Disagreements were
resolved by consensus. For inclusion, the articles needed to
describe a descriptive or interventional study involving the
use of a clinical diagnostic system to diagnose tuberculosis
in pediatric patients. Only English language articles were
included. Pediatric patients were described as individuals less
than 18 years of age. Clinical diagnostic systems included
both scoring systems and diagnostic criteria. Scoring systems
were defined as point-based criteria with set numerical
cutoﬀs for a positive diagnosis. Diagnostic criteria were
defined as nonpoint-based systems in which a certain
number of criteria out of the total or out of each group
were needed for diagnosis. Studies analyzing the diagnosis of
pediatric tuberculosis in general without using or evaluating
a particular scoring system or diagnostic criteria were used
as background information only for the review. Each article
was analyzed to determine the study setting, study design and
methods, sample characteristics, type of diagnostic system
used, reference or gold standard used for comparison, and
eﬀorts at validation of the diagnostic system. We excluded
duplicate publications of the same findings.
3. Results
The systematic literature search identified 2261 articles. The
online search of MEDLINE yielded 2011 articles, and the
search of EMBASE yielded 250 articles, many of which were
also found by the MEDLINE search. Additional potential
studies were identified through searches of bibliographies.
After articles that did not address the diagnosis of tuberculo-
sis in children were excluded, 408 articles remained. Further
articles were excluded upon closer review because they did
not include pediatric patients, did not include a scoring
system or diagnostic criteria, or focused only on screening for
latent tuberculosis. Articles that briefly mentioned a scoring
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Table 1: Point-based scoring systems and studies evaluating these systems.
Author Year Country Scoring criteria Changes Study type
Stegen et al. [7] 1969 Chile Kenneth Jones New Review with case reports
Mathur et al. [9] 1974 India Kenneth Jones Added marasmus to original criteria Prospective observational
Nair and Philip [10] 1981 India Kenneth Jones
Changed point values, took away
negative points for BCG, added re-
sponse to treatment
Prospective
Seth [11] 1991 India Kenneth Jones Used Nair’s adaptation Book excerpt
Shah et al. [12] 1992 India Kenneth Jones
Added history of measles/whooping
cough
Prospective observational
Mehnaz and Arif [13] 2005 Pakistan Kenneth Jones
Modified multiple criteria, added
and subtracted criteria
Retrospective case control
Oberhelmen et al. [14] 2006 Peru Stegen-Toledo No modifications Prospective observational
Viani et al. [8] 2008 Mexico Stegen-Toledo Added points for positive stain Retrospective chart review
Edwards [15] 1987
Papau New
Guinea
Keith Edwards Original Review article
van Beekhuizen [16] 1998
Papua New
Guinea
Keith Edwards No modifications Prospective observational
Weismuller et al. [17] 2002 Malawi
WHO score
chart (modified
Keith Edwards)
Added no response to malaria treat-
ment, modified language
Cross-sectional
observational study
van Rheenen [18] 2002 Zambia Keith Edwards Modified language Prospective cohort
Narayan et al. [19] 2003 India Keith Edwards
Added no response to malaria treat-
ment
Prospective observational
Sant’Anna et al. [24] 2006 Brazil
Brazil Ministry
of Health
New Retrospective case control
Sant’Anna et al. [25] 2004 Brazil
Brazil Ministry
of Health
No modifications Retrospective
Pedrozo et al. [23] 2009 Brazil
Brazil Ministry
of Health
No modifications Prospective observational
Fourie et al. [27] 1998 Multiple New
Set up new scoring criteria by con-
sensus decision
Retrospective
Bergman [28] 1995 Zimbabwe New New Review
system but did not give details or include how it was used in
the study were also excluded. Forty articles met the general
study criteria.
3.1. Clinical Diagnostic Systems Used for TB Diagnosis. From
the forty articles that included a clinical diagnostic system,
we extracted information on the setting, location, sample
size, type of system/criteria used, eﬀorts at validation, choice
of gold standard, and the eﬀect of HIV coinfection in the
population. The characteristics of these studies, including the
validation strategies, are summarized in Tables 1, 2, and 3.
Eighteen studies used scoring systems; these studies could
be further divided into five groups based on a common
initial system modified by diﬀerent authors (Table 1). The
three major groups were the following: (1) the Kenneth
Jones/Stegen-Toledo system [7–14]; (2) the Keith Edwards
system [15–19]; (3) the Brazil Ministry of Health (MOH)
system [23–25]. Fourie et al. [27] and Bergman [28] also
presented new systems without further published studies.
Eighteen studies used diagnostic criteria. These studies could
be further divided into five groups of diagnostic criteria
presented by Ghidey and Habte [29], Migliori et al. [30],
Mahdi et al. [31], Salazar et al. [32], Marais et al. [26], the
WHO guidelines [33–42], Osborne [43], Jeena et al. [44],
and Ramachandran [45] (Table 2). Four articles compared
two or more scoring criteria [46–49] (Table 3).
3.2. Validation of Clinical Diagnostic Systems for Pediatric TB
Diagnosis. Of the above forty articles, sixteen attempted to
validate the diagnostic system or systems (Table 4). Gold
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Table 2: Diagnostic classifications and studies evaluating these classifications.
Author Year Country Scoring criteria Changes Study type
Ghidey and Habte
[29]
1983 Ethiopia New New Prospective
Migliori et al. [30] 1992 Uganda
Migliori—revised from Ghidey
and Habte
Focused towards PTB, added re-
sponse to treatment as a criteria
Prospective
Madhi et al. [31] 1999 South Africa Migliori No change Prospective
Salazar et al. [32] 2001 Peru Migliori
Removed response to treatment.
Created Peru criteria.
Prospective
cohort
Marais et al. [26] 2006 South Africa New Symptom based approach Prospective
World Health
Organization [20]
1983 Multiple New New New guidelines
Cundall [33] 1986 Kenya 1983 WHO guidelines Modifies by adding family contact Prospective
Stoltz et al. [34] 1990 South Africa Modified 1983 WHO guidelines No change Prospective
Beyers et al. [35] 1994 South Africa 1983 WHO guidelines No change Prospective
Gie et al. [36] 1995 South Africa Modified 1983 WHO guidelines No change Prospective
Schaaf et al. [37] 1995 South Africa 1983 WHO guidelines No change Prospective
Houwert et al.
[38]
1998 South Africa 1994 WHO guidelines No change Prospective
Kiwanuka et al.
[42]
2001 Malawi 1983 WHO guidelines
Modified by using only certain radi-
ological findings or positive TST for
probable TB
Prospective
Palme et al. [39] 2002 Ethiopia Modified 1983 WHO guidelines Required 2/6 criteria
Prospective
case-control
Theart et al. [40] 2005 South Africa Modified 1983 WHO guidelines No change Retrospective
Cohen et al. [41] 2008 UK 2006 WHO classification No change Retrospective
Osborne [43] 1995 Zambia Lusaka’s UTH Criteria New Review article
Jeena et al. [44] 1996 South Africa Lusaka’s UTH criteria No change Prospective
Ramachandran
[45]
1968 India New New
Prospective and
retrospective
Table 3: Studies evaluating and comparing multiple diagnostic systems.
Author Year Country Findings
Hesseling et al.
[21]
2002 South Africa
Analyzed 16 diagnostic systems, specifically looks at how systems have been adapted for HIV-
infected and malnourished patients.
Edwards et al.
[47]
2007 Congo
Analyzed 8 scoring systems, found correlation to be poor to moderate. Decision to initiate
treatment for TB was dependent on scoring system used in 14% of children. Selection had a
greater impact in HIV-infected patients.
Ahmed et al.
[48]
2008 Bangladesh Reviews previous scoring systems as well as Hesseling et al. [21] and Edwards et al. [47]
Raqib et al.
[49]
2009 Bangladesh
Analyzed a new diagnostic test (ALS assay) detecting antibodies secreted from circulating MTB-
specific plasma cells in comparison to the Kenneth Jones and WHO/Keith Edwards scoring
criteria as well as clinical diagnosis.
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Table 4: Studies attempting validation of diagnostic systems.
Author Year Country Scoring criteria Validation Gold standard
Point-based scoring systems
Mathur et al. [9] 1974 India Kenneth Jones
Sens 73% (original criteria)
Sens 95% (modified criteria)
Clinical diagnosis
Shah et al. [12] 1992 India Kenneth Jones
Compared modified criteria to pre-
vious Kenneth Jones
Previous KJ
Mehnaz and Arif
[13]
2005 Pakistan Kenneth Jones Retrospective analysis
Clinical control and response to
treatment
Viani et al. [8] 2008 Mexico Stegen-Toledo Retrospective analysis Clinical diagnosis
van Beekhuizen
[16]
1998
Papua New
Guinea
Keith Edwards Sens 62%, spec 95%
Improvement on anti-TB treat-
ment or positive CXR
Weismuller et al.
[17]
2002 Malawi
WHO score
chart (modified
Keith Edwards)
Sens 61% for all types of TB; 54% for
PTB and 73% for EPTB
Clinical diagnosis—diﬀered by
various hospitals
van Rheenen [18] 2002 Zambia Keith Edwards
Sens 88%, spec 25%, PPV 55%,
NPV 67%
Diagnostic algorithm
Narayan et al. [19] 2003 India Keith Edwards Sens 91%, spec 88% Clinical diagnosis
Sant’Anna et al.
[24]
2006 Brazil
Brazil Ministry
of Health
Sens 89%, spec 86%
Culture positive and respiratory
symptoms and/or CXR improved
using exclusively anti-TB drugs
Sant’Anna et al.
[25]
2004 Brazil
Brazil Ministry
of Health
82% very likely, 16% possible, 2.4%
unlikely
Clinical criteria and response to
treatment
Pedrozo et al. [23] 2009 Brazil
Brazil Ministry
of Health
Median score of TB positive groups
higher than negative
Clinical criteria
Fourie et al. [27] 1998 Multiple New
Analyzed by age and country group:
sens 30–73%, spec 10–75%, PPV
50–82%
Positive radiologic or bacterio-
logical data
Diagnostic classification
Migliori et al. [30] 1992 Uganda Migliori
Gastric aspirate: sens 96.8%, spec
92.2%, PPV 68.2%, NPV 99.4%.
Response to treatment: sens 62.5%,
94.1%, PPV 57.7%, NPV 95.1%
Original Ghidey and Habte crite-
ria
Salazar et al. [32] 2001 Peru Migliori
Sens 92% (Migliori) versus 80%
(Peru). 3/3 Peru criteria had 73%
PPV
Migliori criteria (without RTT)
Marais et al. [26] 2006 South Africa New
Children ≥3 and HIV uninfected:
sens 82.3%, spec 90.2%, PPV 82.3%.
Children <3 and HIV uninfected:
sens 51.8%, spec 92.5%, PPV 90.1%.
HIV infected: sens 56.2%, spec
61.8%, PPV 61.9%
Clinical criteria
Houwert et al. [38] 1998 South Africa
WHO
provisional
guidelines
(1994)
PPV of all 3 criteria when present
simultaneously: 63%
WHO diagnostic categories from
1994 used as the gold standard
Sens: sensitivity; spec: specificity; PTB: pulmonary tuberculosis; EPTB: extrapulmonary tuberculosis; PPV: positive predictive value; NPV: negative predictive
value.
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standards used in validation varied greatly and ranged from
positive cultures to clinical diagnosis to previous scoring
criteria. The only study using cultures as the primary gold
standard was Sant’Anna et al. [24], which found a sensitivity
of 89% and specificity of 86% when evaluating Brazil
Ministry of Health criteria against a standard of culture-
positive patients. Sant’Anna et al. [25] also performed a
retrospective analysis on a diﬀerent study population using
clinical consensus as the gold standard against which to com-
pare the diagnostic criteria, resulting in similar sensitivity.
Culture for Mycobacterium tuberculosis is less sensitive in
pediatric patients and diﬃcult to obtain in resource-limited
settings; therefore, the most common gold standard used
to validate diagnostic systems was clinical diagnosis. The
definition of clinical diagnosis varied widely between studies
and was often not defined in detail. Because many of the
studies were retrospective, clinical diagnosis was often simply
defined as children who had been admitted with a diagnosis
of TB [8, 34], with some studies also specifying that the
children must have improved on anti-TB medication [13, 40,
41]. In one article, the study population was drawn from
forty-four diﬀerent hospitals, all of which used their own
methods of clinical diagnosis [17]. However, in other studies,
the method of clinical diagnosis was explained in depth. For
example, van Rheenen described a detailed algorithm that
included clinical findings, culture, CXR, TST, contact history,
and response to treatment [18].
Previously described scoring criteria were also used as a
gold standard; a few of the studies compared their mod-
ifications of a certain diagnostic system to the original.
For example, Migliori et al. modify the criteria published
by Ghidey and Habte [29] by focusing the criteria on
pulmonary TB and adding response to treatment and use the
original criteria as the gold standard in their analysis [30].
Salazar et al. then modified the Migliori criteria to develop
the Peru criteria, and used the original Migliori criteria as the
gold standard for comparison [32]. These are not traditional
validation strategies as they assume the previous criteria have
been validated to an extent that they may now be considered
a gold standard in themselves.
Four published papers evaluated and compared multiple
scoring systems and diagnostic criteria (Table 3). In a 2002
systematic review, Hesseling et al. stressed the need for
standardization of definitions and point values between the
various algorithms [21]. As an update on Hesseling’s review,
this current review includes twenty-one new studies, includ-
ing those evaluating the Brazil MOH scoring system [23–25]
and the Marais criteria [26]. In 2008, Ahmed et al. published
a review of TB diagnosis as well as treatment, focusing
mainly on the Kenneth Jones and Keith Edwards systems [48]
and suggesting the need for further research. Most recently,
in 2009, Raquib et al. compared a newer diagnostic test
(ALS assay) to clinical diagnosis, the Kenneth Jones, and the
Keith Edwards scoring criteria [49], finding that sensitivity,
specificity, and overall concordance was higher when the ALS
assay was compared to clinical diagnosis than to the scoring
criteria.
In a 2007 article, Edwards et al. used data from a
retrospective review of TB cases at a pediatric hospital with
a highprevalence of HIV infection to calculate scores for
eight diagnostic scoring systems [47]. The decision to initiate
treatment for TB was dependent on the scoring system
used, with at least one scoring system recommending not
to treat for 14% of the children studied. Except for the
systems derived from a common original diagnostic system,
correlation was poor to moderate for agreement of when to
initiate treatment based on the various scoring systems.
3.3. Variation among Criteria. Although all of the scoring
criteria have aspects in common, their purposes and specifics
have varied over the past 40 years since Stegen et al. published
the original Kenneth Jones criteria. The Kenneth Jones
criteria include laboratory tests but exclude clinical criteria
such as cough and fever due to concerns that they would
lower the specificity [7]. In contrast, the purpose of the Keith
Edwards criteria was focused towards a completely clinical
diagnosis, and thus excluded laboratory data except for a TST
[15].
Both the Kenneth Jones and Keith Edwards criteria
were designed for the diagnosis of both pulmonary and
extrapulmonary tuberculosis. Because the clinical signs and
symptoms of extrapulmonary tuberculosis may diﬀer from
those of pulmonary tuberculosis, several studies evaluated
the ability of diagnostic strategies to identify pulmonary
TB specifically (Table 5). For example, the Brazil MOH
system, designed specifically for pulmonary tuberculosis [24,
25], has shown a sensitivity of 89% and a specificity of
86%. The Migliori [30] and Marais [26] diagnostic criteria,
also focused on pulmonary tuberculosis, demonstrated a
sensitivity of 92% [31] and 82%, respectively. While the
Migliori criteria have not been tested in children with
coinfection, the sensitivity of the Marais criteria decreased
to 51–56% when children under three years of age and HIV
infected children were included [26].
A salient diﬀerence between the various clinical diag-
nostic approaches was the choice of included criteria. The
criteria included most commonly were the tuberculin skin
test (TST) and positive history of TB contact; however,
the definition of these criteria was not standardized. For
example, the definition of a positive TST varies widely
among studies [7, 15]. A positive history of TB contact also
was defined in various ways, such as requiring confirmed
sputum-positive contact [37] or only a self-report of contact
[30]. In some cases, the history of contact had to be within
the past two years [14]. Using both the TST and the positive
contact history may also be redundant if both are included.
Variability is also seen in the other criteria, such as clinical
symptoms and CXR. The various definitions and subjectivity
of many of the criteria included in the diagnostic approaches
make it diﬃcult to compare the diagnostic strategies and the
attempts at validation. In addition, clinicians likely vary in
how they implement the scoring criteria, thus, making the
diagnostic thresholds even less consistent.
3.4. Clinical Diagnostic Systems in HIV-Infected Patients.
A few studies specifically examined TB diagnosis in HIV-
infected children (Table 6). In his comparison of eight
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Table 5: Studies focusing primarily on pulmonary tuberculosis.
Author Year Country Scoring system Percent also with EPTB Validation
Shah et al. [12] 1992 India
Modified
Kenneth Jones
Looked at “primary complex”
(just pulmonary) versus “pro-
gressive primary complex” (pul-
monary plus LAD)
Not analyzed, just used in inclu-
sion criteria
Migliori et al. [30] 1992 Uganda Migliori All pulmonary
Gastric aspirate: sens 96.8%,
spec 92.2%, PPV 68.2%, NPV
99.4%. Response to treatment:
sens 62.5%, 94.1%, PPV 57.7%,
NPV 95.1%
Beyers et al. [35] 1994 South Africa
Modified 1883
WHO criteria
All pulmonary—excluded extra-
pulmonary tuberculosis without
lung involvement
Not evaluated
Salazar et al. [32] 2001 Peru Migliori
All pts had PTB, 21/135 had
EPTB as well: lymphadenopa-
thy, intestinal-intraperitoneal TB,
intra-abdominal lymphadenopa-
thy, miliary disease, meningitis,
and optic involvement. 3 with
EPTB did not meet criteria for
PTB
Sens 92% (Migliori) versus 80%
(Peru). 3/3 Peru criteria had 73%
PPV
Sant’Anna et al. [25] 2004 Brazil
Brazil Ministry
of Health
82% very likely, 16% possible,
2.4% unlikely
All pulmonary plus 5 pts with
assoc extrapulmonary TB
Sant’Anna et al. [24] 2006 Brazil
Brazil Ministry
of Health
Cut oﬀ ≥40: sens 58% and spec
98% but missed 42% of con-
firmed PTB.
Cut oﬀ ≥30: sens 89% and spec
86%
Pulmonary
Oberhelmen et al. [14] 2006 Peru Stegen-Toledo
Not analyzed, just used in inclu-
sion criteria
Pulmonary
Marais et al. [26] 2006 South Africa New
Children≥3 and HIV uninfected:
sens 82.3%, spec 90.2%, PPV
82.3%.
Children <3 and HIV uninfected:
sens 51.8%, spec 92.5%, PPV
90.1%. HIV infected: sens 56.2%,
spec 61.8%, PPV 61.9%
Focused on pulmonary TB only
Viani et al. [8] 2008 Mexico Stegen-Toledo
Looked retrospectively: 10/13
highly probable, 2/13 probable,
1/13 suspicious
100% pulmonary, 54% also had
disseminated
Pedrozo et al. [23] 2009 Brazil
Brazil Ministry
of Health
Analyzed scoring system by look-
ing at median scores of vari-
ous groups: median score of 3a
and 3b sig. higher than 1 and
2, median score also was higher
than the cut oﬀ of 30
Pulmonary only
Sens: sensitivity; spec: specificity; PTB: pulmonary tuberculosis; EPTB: extrapulmonary tuberculosis; PPV: positive predictive value; NPV: negative predictive
value.
diagnostic scoring systems, Edwards showed that HIV-
infected children tended to have higher scores, especially
when the Keith Edwards system was used, leading to a
concern for over-diagnosis of TB in HIV-infected children
[47]. Marais et al. found that the Marais diagnostic criteria
were less sensitive (56% compared to 82%) and less specific
(62% compared to 90%) when evaluating children with HIV
as opposed to children without HIV. The positive predictive
value also decreased to 62% in HIV-infected children as
compared to 82% in children without HIV [26]. Viani et al.
looked at a small cohort of coinfected children in Mexico
retrospectively and found that 77% had scores indicating
highly probable TB when using the Stegen-Toledo criteria
[8]. Finally, in a 2009 analysis of the Brazil MOH criteria,
Pedrozo et al. found that while coinfected children did score
slightly lower than HIV-uninfected children, their scores
were still significantly higher than children without TB
[25].
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Table 6: Studies that specified how many patients were coinfected with HIV.
Author Year Country Total patients Percent HIV positive Findings
Madhi et al. [31] 1999 South Africa 130 40%
Did not attempt to validate scoring crite-
ria
Kiwanuka et al. [42] 2001 Malawi 110 71% (of 102 tested)
Did not attempt to validate scoring crite-
ria
Palme et al. [39] 2002 Ethiopia 517 11.2%
Did not attempt to validate scoring crite-
ria
van Rheenen [18] 2002 Zambia 147 30%
Keith Edwards scoring system: sensitivity
88% and specificity 25% in this study.
Most of the children with a false positive
score were malnourished (48%) or had
AIDS (31%)
Marais et al. [26] 2006 South Africa 428 8.8%
Sensitivity, specificity, and PPV all de-
creased significantly when HIV infected
children included
Edwards et al. [47] 2007 Democratic Republic
of Congo
91 46%
Out of 8 scoring systems analyzed, 3/8
systems did not recommend treatment in
14% of HIV-infected children compared
to 2% of noninfected children. Mean
score tended to be higher for HIV-infected
children, but only significant for Edwards
score
Viani et al. [8] 2008 Mexico 13 100%
Applied Stegen-Toledo criteria retrospec-
tively but without culture results: 77% had
highly probable TB, 15% probable, and
8% suspicion of TB
Pedrozo et al. [23] 2009 Brazil 239 5%
Analyzed scoring system by looking at
median scores of various groups: median
score of 3a (TB+, HIV−) and 3b (TB+,
HIV+) sig. higher than TB negative
groups, median score of TB+ groups also
was higher than the cutoﬀ of 30
PPV: positive predictive value.
4. Discussion
We identified and reviewed forty diﬀerent studies of twenty-
two unique scoring systems or diagnostic criteria that were
developed from five original scoring systems and five original
diagnostic criteria. These diagnostic approaches varied in
the types of clinical signs and symptoms included in the
criteria, the inclusion or exclusion of laboratory testing, and
even their diagnostic focus (i.e., pulmonary TB alone or
pulmonary and extrapulmonary TB). Studies designed to
validate the various diagnostic systems varied significantly
in the gold standard chosen for comparison. Because the
publication dates of the articles range over the last fifty years,
some criteria were developed and evaluated prior to the
HIV epidemic, while other studies focused specifically on
coinfected children.
The gold standards chosen to evaluate the validity of
these diagnostic strategies also varied widely. Cultures can be
diﬃcult to obtain in children. Because tuberculous disease
in children is often pauci-bacillary, the diagnostic yield
of cultures in children is often poor. Although one study
used culture as the gold standard [25], others used positive
response to treatment [13], CXR [35], or a previous scoring
criteria [30]. The most common gold standard was clinical
diagnosis. Interestingly, in a study of the ALS assay for
diagnosing active TB disease, the assay actually correlated
better with clinical diagnosis than either the Kenneth Jones
or Keith Edwards scoring criteria [49]. Unfortunately, clinical
diagnosis is likely to depend strongly upon the experience
and knowledge base of the clinician and thus may be less
reliable in settings where clinicians have less training. To
allow for comparison of criteria across diﬀerent studies and
settings, future studies need to employ a more consistent
gold standard. Ideally, this would be culture-based, as this
is a standard for validation that could be reliably replicated
across settings. However, because cultures are diﬃcult to
obtain in resource-limited settings and can lead to a delay
in treatment, performing studies with culture as the gold
standard can be diﬃcult.
In addition to using a variety of gold standards, the vari-
ous studies often included very diﬀerent sample populations.
Some studies did not clearly describe the characteristics of
the patient population or how they were selected. Many
were retrospective, often utilizing chart review. Ideally,
prospective studies of diagnostic systems would evaluate a
clearly defined sample of participants with a spectrum of
AIDS Research and Treatment 9
disease that is representative of the patients to which the
criteria would be applied in clinical practice. It is essential
that researchers clearly describe the sample selection process
and inclusion criteria in such studies to allow for more
accurate comparisons of criteria across diﬀerent populations
or settings and to promote the utility of these systems in
clinical practice.
Another challenge in prospective studies of TB diagnosis
is the bias that is introduced when, as found in some of these
studies, the inclusion or screening criteria for participants
often include similar clinical features as the diagnostics
systems being evaluated. For example, Pedrozo et al. used
history of contact, CXR, and TST result as part of the criteria
for inclusion in the study. Chest X-ray and TST were also
used as part of their diagnostic gold standard to diﬀerentiate
latent TB from no TB from active TB disease. All three
inclusion criteria are also used in the Brazil MOH scoring
system being evaluated in this study [25]. This makes it
diﬃcult to interpret the accuracy of a diagnostic system and
its ability to predict a diagnosis of TB in a particular patient
or patient population. This overlap also causes diﬃculty in
determining the relative importance of particular signs or
symptoms within the diagnostic system.
The largest shift in the newer diagnostic systems as
compared to Kenneth Jones and Keith Edwards is the
focus on pulmonary tuberculosis alone. Diagnostic systems
focusing simply on pulmonary TB, such as the Brazil MOH
and Marais criteria, have demonstrated higher sensitivities
and specificities than those developed to diagnose both
extrapulmonary and pulmonary TB. Because children have
a higher incidence of extrapulmonary TB [50], using diag-
nostic systems targeted at pulmonary TB only addresses part
of the diagnostic challenge. On the other hand, because
TB presents with varied signs and symptoms depending
on the site of disease, it is diﬃcult to conceive of a
single diagnostic system that could diagnose with high
sensitivity and specificity the various types of tuberculosis
infections (e.g., vertebral, abdominal, and pulmonary TB).
Furthermore, many children with extrapulmonary TB also
have pulmonary disease [51]. A new system of classifica-
tion, focusing on the severity of the disease rather than
location, has recently been published and may also be
a more reliable and reproducible method. If this is well
validated in diﬀerent settings, it may allow various diagnostic
systems to be better compared than is currently possible
[52].
At this time, the Brazil MOH scoring system has the
most studies evaluating its validity with consistently high
sensitivities and specificities. In each of the three studies of
this criteria, the scoring system was tested against a slightly
diﬀerent gold standard, ranging from clinical criteria [23, 25]
to culture-proven disease [24]. Although this may make
some comparisons diﬃcult with the lack of a standard gold
standard, the fact that the scoring system holds up fairly
well when tested in diﬀerent ways actually strengthens the
evidence for its validity. Though it has not been tested
outside of Brazil, it has been tested in both an inpatient
[24] and outpatient setting [23, 25]. The performance of
the scoring system has also been evaluated in HIV-infected
patients. These coinfected children still scored significantly
above the cutoﬀ for a diagnosis of TB [23]. All of these
evaluations point favorably toward the validity of this
scoring system. Evaluating the Brazil MOH scoring system in
additional settings worldwide should be an important next
step.
The findings of this systematic review are limited by
the design and quality of the studies included. The lack of
consistent and sometimes clearly defined inclusion criteria
among the studies makes it diﬃcult to compare sensitivity
and specificity across the diﬀerent diagnostic systems. Most
of the various diagnostic systems have only been evaluated
in specific geographic locations or single populations; few
studies evaluate a particular diagnostic system in multiple
geographic regions or patient populations. Fewer studies
have compared the diagnostic yield of multiple criteria in
the same patient population. Finally, the increase in the
prevalence of HIV during the publication range of these
studies makes it diﬃcult to compare studies from thirty years
ago to those more recently published. Although this paper
includes more than twenty new studies since Hesseling et al.
was published in 2002 [21], the number of articles assessing
the validity of each diagnostic system is still relatively small.
The paper also did not include unpublished data or non-
English publications.
5. Conclusion
Clinical diagnostic systems in use for many years (e.g., the
original Kenneth Jones criteria) and those more recently
developed (e.g., the Brazil MOH criteria) have generally
been developed, and subsequently adapted, in an attempt to
accurately and reliably diagnose tuberculosis in children. As
more continues to be learned about the disease and newer,
more accurate tests are developed, methods of diagnosis will
likely be altered further. It remains crucial that these methods
remain applicable to resource-limited settings where the
majority of children with TB are still most likely to be
found. Although the studies included in this paper are
heterogeneous and diﬃcult to compare, the Brazil MOH
criteria seems to emerge as the best validated in children
with TB alone as well as those coinfected with TB and
HIV. Due to the diﬃculty with obtaining cultures and the
expense of the newer diagnostic tests, clinical scoring systems
and diagnostic criteria will likely continue to be necessary
in resource-limited settings for some time. However, unless
additional studies identify refined diagnostic systems with
improved sensitivity and specificity, they will likely mainly
be utilized as initial screening tools or adjuncts to support
clinical diagnosis. Improving the accuracy of diagnosis of
pediatric TB is needed to ensure appropriate and timely
treatment of those with active disease and to prevent unnec-
essary morbidity and mortality. Validated clinical diagnostic
systems that can be implemented in resource limited settings
can improve the accuracy and timeliness of tuberculosis
in children; however, additional well-designed studies are
needed to validate the accuracy and reliability of current
scoring systems and diagnostic criteria.
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